cardamine: I get the concern that you and many oth
Post# of 151575
Dr McKary is an oncology surgeon from Johns Hopkins Hospital, and has preached rigorous science based decision making processes. Given how the previous FDA has treated Leronlimab, I'm more than curious to see how this new umpire calls balls and strikes when Leronlimab comes to the plate.

